Deerfield Management Company, L.P. (Series C) Rhythm Pharmaceuticals, Inc. Transaction History

Deerfield Management Company, L.P. (Series C)

$5.38 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$6.13 - $12.24 $9.66 Million - $19.3 Million	-1,576,462 Reduced 84.42%	291,005 $3.35 Million
Q4 2021 Feb 14, 2022	SELL	$8.62 - $13.9 $1.05 Million - $1.7 Million	-122,158 Reduced 6.14%	1,867,467 $18.6 Million
Q1 2021 May 17, 2021	SELL	$20.25 - $39.49 $14.8 Million - $28.9 Million	-731,578 Reduced 26.88%	1,989,625 $42.3 Million
Q4 2020 Feb 16, 2021	BUY	$21.17 - $32.61 $17.4 Million - $26.9 Million	824,156 Added 43.44%	2,721,203 $80.9 Million
Q3 2020 Nov 16, 2020	SELL	$18.13 - $30.61 $10.4 Million - $17.5 Million	-572,966 Reduced 23.2%	1,897,047 $41.1 Million
Q2 2020 Aug 14, 2020	SELL	$14.41 - $25.35 $8.09 Million - $14.2 Million	-561,552 Reduced 18.52%	2,470,013 $55.1 Million
Q1 2020 May 15, 2020	SELL	$13.16 - $22.9 $16.6 Million - $28.8 Million	-1,257,726 Reduced 29.32%	3,031,565 $46.1 Million
Q4 2019 Feb 14, 2020	BUY	$19.53 - $25.5 $33.2 Million - $43.4 Million	1,700,000 Added 65.66%	4,289,291 $98.5 Million
Q3 2019 Nov 14, 2019	BUY	$18.62 - $24.51 $36.6 Million - $48.2 Million	1,965,358 Added 315.0%	2,589,291 $55.9 Million
Q2 2019 Aug 14, 2019	BUY	$21.11 - $28.48 $7.03 Million - $9.48 Million	332,928 Added 114.41%	623,933 $13.7 Million
Q4 2018 Feb 14, 2019	SELL	$24.11 - $31.34 $1.8 Million - $2.34 Million	-74,684 Reduced 20.42%	291,005 $7.82 Million
Q3 2018 Nov 14, 2018	SELL	$26.99 - $35.85 $9.12 Million - $12.1 Million	-337,911 Reduced 48.03%	365,689 $10.7 Million
Q2 2018 Aug 14, 2018	BUY	$17.02 - $35.2 $2.07 Million - $4.28 Million	121,590 Added 20.89%	703,600 $22 Million
Q4 2017 Feb 14, 2018	BUY	$22.0 - $30.51 $12.8 Million - $17.8 Million	582,010	582,010 $16.9 Million

Others Institutions Holding RYTM

# of Institutions

192

Shares Held

67.3M

Call Options Held

834K

Put Options Held

78.6K

Primecap Management CO Pasadena, CA

7.22M
Shares

$448 Million
0.28% of portfolio
Black Rock Inc. New York, NY

6.74M
Shares

$418 Million
0.01% of portfolio
Baker Bros. Advisors LP New York, NY

6.4M
Shares

$397 Million
3.59% of portfolio
Ra Capital Management, L.P. Boston, MA

6.08M
Shares

$377 Million
4.44% of portfolio
Goldman Sachs Group Inc New York, NY

3.88M
Shares

$241 Million
0.03% of portfolio

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.46B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account